about the conference
About the Conference
The theme for iMig 2025 is “Fostering Global Collaboration.” In addition to the traditional well-balanced presentations from the top international experts and the most exciting cutting-edge research that has come to be the hallmark of iMig conferences, this year we will be doing something new.
Beyond the usual informal networking that makes iMig one of the most anticipated and productive cancer conferences in the world, this year all attendees will be invited to join in a structured networking session each day of the conference, culminating in the generation of two international collaborations – one translational research project and one clinical trial.
This iMig will conclude with the Keynote address by Dr. Stephen Hahn on the art of the possible that can be achieved working as a team. Dr. Hahn, internationally acclaimed radiation oncologist and researcher, served as the Director of the FDA during the height of the pandemic and managed the team effort that resulted in production of the life-saving COVID vaccine in record time. This address will be followed by presentation of the two teamwork projects generated at the 2025 iMig and will lay the path forward for attendees to participate in these projects.
Conference Live Dates:
October 26 - 29, 2025
Conference Location:
Philadelphia Marriott Downtown Philadelphia, PA 19107 United States Tel: 215-625-6014
Impotant Dates
Abstract Submission Opens |
January 9, 2025 |
Registration Opens |
January 9, 2025 |
Abstract Submission Deadline |
May 21, 2025 |
Abstract Review |
May 26 – Jun 6 |
Abstract Scheduling |
Jun 16 – 27, 2025 |
Abstract Notifications |
July 3, 2025 |
Early Registration Deadline |
July 18, 2025 |
Presenting Author Reg. Deadline |
September 12, 2025 |
Regular Registration Deadline |
September 12, 2025 |
Conference |
Oct 26 – 29, 2025 |